Home/Filings/4/0001654954-24-015475
4//SEC Filing

Hunter Robyn 4

Accession 0001654954-24-015475

CIK 0000034956other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 8:04 PM ET

Size

6.8 KB

Accession

0001654954-24-015475

Insider Transaction Report

Form 4
Period: 2024-12-10
Hunter Robyn
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-10+100,000100,000 total
    Exercise: $5.94From: 2025-12-10Exp: 2034-12-10Common Stock (100,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $992.00From: 2023-06-09Exp: 2032-06-09Common Stock (4 underlying)
    4
Footnotes (1)
  • [F1]These options were previously reported as covering 6,250 shares at an exercise price of $0.62 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeother

Related Parties

1
  • filerCIK 0001713932

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 8:04 PM ET
Size
6.8 KB